These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 7377063
21. Sulphinpyrazone in the prevention of cardiac death after myocardial infarction. S Afr Med J; 1980 Mar 01; 57(9):301-2. PubMed ID: 6986664 [No Abstract] [Full Text] [Related]
22. The Anturane reinfarction trial. Sherry S. Thromb Haemost; 1979 Feb 28; 41(1):197-201. PubMed ID: 483231 [No Abstract] [Full Text] [Related]
23. [Prevention of sudden cardiac death]. Bender F. Verh Dtsch Ges Herz Kreislaufforsch; 1980 Feb 28; 46():65-72. PubMed ID: 6113721 [No Abstract] [Full Text] [Related]
24. Sulfinpyrazone after myocardial infarction. Nestel PJ. Med J Aust; 1980 Jun 14; 1(12):571-2. PubMed ID: 7402151 [No Abstract] [Full Text] [Related]
25. [Treatment with sulfinpyrazone in comparison with ditazol. Use of dynamic ECG for the study of the cardiac rhythm in patients with recent acute myocardial infarction]. Racco F, Palermo R, Agostinelli MC, Melappioni A, Ganzetti S, Conti V, Amadio E. Clin Ter; 1983 Feb 28; 104(4):287-96. PubMed ID: 6134600 [No Abstract] [Full Text] [Related]
26. [Can sudden cardiac death be prevented?]. Gross F. MMW Munch Med Wochenschr; 1982 Jan 08; 124(1):27-31. PubMed ID: 6120453 [No Abstract] [Full Text] [Related]
28. Sulphinpyrazone, aspirin, and uric acid. Walter E, Staiger C. Lancet; 1980 May 24; 1(8178):1131. PubMed ID: 6103456 [No Abstract] [Full Text] [Related]
29. Myocardial re-infarction and sulphinpyrazone. N Z Med J; 1978 Aug 09; 88(617):106. PubMed ID: 362256 [No Abstract] [Full Text] [Related]
30. [Sudden death among 1,000 patients with myocardial infarction: incidence and contributory factors. KYSMI Study Group]. Kambara H, Kinoshita M, Nakagawa M, Sakurai T, Kawai C. J Cardiol; 1995 Feb 09; 25(2):55-61. PubMed ID: 7897607 [Abstract] [Full Text] [Related]
31. Sulfinpyrazone after myocardial infarction. N Engl J Med; 1978 Jun 01; 298(22):1257-9. PubMed ID: 349383 [No Abstract] [Full Text] [Related]
32. More on sulfinpyrazone after myocardial infarction. Hood WB. N Engl J Med; 1982 Apr 22; 306(16):988-9. PubMed ID: 7038499 [No Abstract] [Full Text] [Related]
33. [Sulfinpyrazone following myocardial infarct]. Schröder R. Dtsch Med Wochenschr; 1980 Apr 11; 105(15):503-4. PubMed ID: 7363815 [No Abstract] [Full Text] [Related]
34. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure. Kuch M, Janiszewski M, Mamcarz A, Cudnoch-Jedrzejewska A, Dłuzniewski M. Med Sci Monit; 2009 Jun 11; 15(6):PH40-8. PubMed ID: 19478711 [Abstract] [Full Text] [Related]
35. [Drug treatment for secondary prevention of myocardial infarction]. Ishikawa K, Kanamasa K, Hayashi T, Takenaka T, Inoki T, Katayama K, Miyataka M, Kimura A, Yabushita H, Taniwa T, Ikeda A. J Cardiol; 2000 Jun 11; 35(6):397-408. PubMed ID: 10884976 [Abstract] [Full Text] [Related]
36. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG. Eur Heart J; 1997 Jan 11; 18(1):41-51. PubMed ID: 9049514 [Abstract] [Full Text] [Related]
37. Sulphinpyrazone (Anturan) after myocardial infarction. Nicholson MR, Whitlock RM. N Z Med J; 1979 Sep 26; 90(644):263. PubMed ID: 390442 [No Abstract] [Full Text] [Related]
38. Sulphinpyrazone and renal function following myocardial infarction. Choudhury SL, Taylor SH, Wieringa G, Swaminathan R, Morgan DB. Eur J Clin Pharmacol; 1983 Sep 26; 24(6):747-50. PubMed ID: 6884411 [Abstract] [Full Text] [Related]
39. FDA says no to anturane. Kolata GB. Science; 1980 Jun 06; 208(4448):1130-2. PubMed ID: 6990491 [No Abstract] [Full Text] [Related]
40. Sulfinpyrazone after myocardial infarction? Beilin LJ. Med J Aust; 1978 Aug 26; 2(5):186-8. PubMed ID: 364265 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]